Literature DB >> 29207691

A Comparative Study of High Sensitivity C-Reactive Protein and Metabolic Variables in Type 2 Diabetes Mellitus with and without Nephropathy.

Abid K Shaheer1, Jithesh K Tharayil2, Parvathi W Krishna3.   

Abstract

INTRODUCTION: Diabetic nephropathy is a serious chronic complication of Type 2 Diabetes Mellitus (T2DM) which impairs the quality of life, leading to increased morbidity and mortality. The high sensitivity C-reactive protein (hs-CRP) is an acute phase reactant which acts as a non-specific systemic marker of inflammation. AIM: To find out the relationship between serum hs-CRP and metabolic variables in Type 2 diabetic patients with and without nephropathy.
MATERIALS AND METHODS: The study group consists of 96 subjects that include non-diabetic healthy controls, Type 2 diabetic patients without any complications and patients with diabetic nephropathy. The study group was composed of both genders, aged 31-70 years, who reported after 10-12 hours overnight fasting; then, venous blood and fresh urine samples were collected, in the morning from all the study subjects. Data were analysed using Statistical Package for the Social Sciences (SPSS). Independent t-test was used to compare between the groups and Chi square test was used to find out the relationship between serum hs-CRP and metabolic variables.
RESULTS: The results showed a significantly (p<0.05) increasing trend of serum hs-CRP with the degree of microalbumin excretion and the severity of nephropathy in Type 2 diabetic patients. The result showed a significant (p<0.05) relationship between hs-CRP and the metabolic variables like Fasting Blood Glucose (FBG), Post Prandial Blood Glucose (PPBG), Total Cholesterol (TC), Triglycerides (TG), LDL-Cholesterol (LDL-C), TC:HDL-Cholesterol (HDL-C) ratio and estimated Glomerular Filtration Rate (eGFR) and no significance (p>0.05) between hs-CRP and HDL-Cholesterol in both diabetic and diabetic nephropathy subjects.
CONCLUSION: Hs-CRP was strongly associated with the metabolic variables and predictors of cardiovascular risk in Type 2 diabetes mellitus with and without nephropathy. The hs-CRP might be considered as a predictor or illness indicator for the development of nephropathy and cardiovascular risk in Type 2 diabetic patients.

Entities:  

Keywords:  Dyslipidemia; Hyperglycemia; Inflammation; Insulin resistance

Year:  2017        PMID: 29207691      PMCID: PMC5713713          DOI: 10.7860/JCDR/2017/30272.10528

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  25 in total

Review 1.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  The urine protein heat coagulation test--a useful screening test for proteinuria in pregnancy in developing countries: a method validation study.

Authors:  Vajira H W Dissanayake; Linda Morgan; Fiona Broughton Pipkin; Veluppillai Vathanan; Samanthi Premaratne; Rohan W Jayasekara; Harshalal R Seneviratne
Journal:  BJOG       Date:  2004-05       Impact factor: 6.531

3.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

4.  C-reactive protein and glycemic control in adults with diabetes.

Authors:  Dana E King; Arch G Mainous; Thomas A Buchanan; William S Pearson
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

5.  Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.

Authors:  Mohammad Javad Mojahedi Mojahedi; Shokoofeh Bonakdaran; Maryam Hami; Mohammad Reza Sheikhian; Mohammad Taghi Shakeri; Hossein Aiatollahi
Journal:  Iran J Kidney Dis       Date:  2009-01       Impact factor: 0.892

Review 6.  Human C-reactive protein and the metabolic syndrome.

Authors:  Sridevi Devaraj; Uma Singh; Ishwarlal Jialal
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

Review 7.  Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis.

Authors:  Ranil Jayawardena; Priyanga Ranasinghe; Nuala M Byrne; Mario J Soares; Prasad Katulanda; Andrew P Hills
Journal:  BMC Public Health       Date:  2012-05-25       Impact factor: 3.295

8.  Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention?

Authors:  Fredric J Pashkow
Journal:  Int J Inflam       Date:  2011-08-11

9.  Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.

Authors:  Shivananda B Nayak; Geetha Bhaktha
Journal:  Lipids Health Dis       Date:  2005-08-10       Impact factor: 3.876

10.  Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy.

Authors:  B Shivananda Nayak; Heidi Duncan; Sunita Lalloo; Kevin Maraj; Vani Matmungal; Felicia Matthews; Bhupinder Prajapati; Ria Samuel; Pearse Sylvester
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  5 in total

Review 1.  Roles of pattern recognition receptors in diabetic nephropathy.

Authors:  Zhi-Feng Zhou; Lei Jiang; Qing Zhao; Yu Wang; Jing Zhou; Qin-Kai Chen; Jin-Lei Lv
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

2.  Association between inflammatory obesity phenotypes, FTO-rs9939609, and cardiovascular risk factors in patients with type 2 diabetes.

Authors:  Meysam Alipour; Hosein Rostami; Karim Parastouei
Journal:  J Res Med Sci       Date:  2020-05-22       Impact factor: 1.852

3.  Serum and Salivary Level of Nitric Oxide (NOx) and CRP in Oral Lichen Planus (OLP) Patients.

Authors:  Atena Shiva; Shahin Arab; Seyyed Jaber Mousavi; Ali Zamanian; Avideh Maboudi
Journal:  J Dent (Shiraz)       Date:  2020-03

Review 4.  Interactions Among Non-Coding RNAs in Diabetic Nephropathy.

Authors:  Tamil Selvi Loganathan; Siti Aishah Sulaiman; Nor Azian Abdul Murad; Shamsul Azhar Shah; Abdul Halim Abdul Gafor; Rahman Jamal; Noraidatulakma Abdullah
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

5.  The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: A meta-analysis.

Authors:  Fengyan Xiao; Feng Gao; Shengxue Zhou; Lina Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.